A Critical N-Nitrosamine Impurity of Anticoagulant Drug, Rivaroxaban: Synthesis, Characterization, Development of LC–MS/MS Method for Nanogram Level Quantification-Reference-Cited by-同舟云学术

A Critical N-Nitrosamine Impurity of Anticoagulant Drug, Rivaroxaban: Synthesis, Characterization, Development of LC–MS/MS Method for Nanogram Level Quantification

Published:2022-01 Issue:1 Volume:85 Page:73-82
ISSN:0009-5893
Container-title:Chromatographia
language:en
Short-container-title:Chromatographia

Author:

Baksam Vijaya Kumar^ORCID,Saritha Nimmakayala,Devineni Subba Rao,Jain Mohit,Kumar Prashanth,Shandilya Sanjeev,Kumar Pramod

Publisher

Springer Science and Business Media LLC

Subject

Organic Chemistry,Clinical Biochemistry,Biochemistry,Analytical Chemistry

Link

https://link.springer.com/content/pdf/10.1007/s10337-021-04115-x.pdf

Reference30 articles.

1. Gyorgy S, Miriam C, Amores D, Marco G, Frederico CF, William H (2015) Genotoxic impurities in pharmaceutical manufacturing: sources, regulations, and mitigation. Chem Rev 115:8182–8229. https://doi.org/10.1021/cr300095f

2. Linda KD, Marvin MH, Brian WP, Todd JP, Steven WB (2013) The assessment of impurities for genotoxic potential and subsequent control in drug substance and drug product. J Pharm Sci 102:1404–1418. https://doi.org/10.1002/jps.23462

3. Amit G, Hussain S, Tabrez S (2018) Genotoxic impurities and its risk assessment in drug compound. DDIPIJ. https://doi.org/10.32474/DDIPIJ.2018.02.000143

4. Rene H, David PE (2016) Analytical advances in pharmaceutical impurity profiling. Eur J Pharm Sci 87:118–135. https://doi.org/10.1016/j.ejps.2015.12.007

5. De la Monte SM, Tong M (2009) Mechanisms of nitrosamine-mediated neurodegeneration: potential relevance to sporadic Alzheimer’s disease. J Alzheimer’s Dis 17(4):817–825. https://doi.org/10.3233/jad-2009-1098

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Analytical Methodologies to Detect N-Nitrosamine Impurities in Active Pharmaceutical Ingredients, Drug Products and Other Matrices;Chemical Research in Toxicology;2024-08-19

2. Bumetanide as a Model NDSRI Substrate: N-nitrosobumetanide Impurity Formation and its Inhibition in Bumetanide Tablets;Journal of Pharmaceutical Sciences;2023-12

3. Performance Characteristics of Mass Spectrometry-Based Analytical Procedures for Quantitation of Nitrosamines in Pharmaceuticals: Insights from an Inter-laboratory Study;Journal of Pharmaceutical Sciences;2023-10

4. Nitrosamine Impurities in Herbal Formulations: A Review of Risks and Mitigation Strategies;Drug Research;2023-07-24

5. Insight into Analytical Techniques for the Detection of Nitrosamine Impurities: A Review;Asian Journal of Pharmaceutical Analysis;2023-03-22